![](/img/cover-not-exists.png)
Ruxolitinib + capecitabine in advanced/metastatic pancreatic cancer after disease progression/intolerance to first-line therapy: JANUS 1 and 2 randomized phase III studies
Hurwitz, Herbert, Van Cutsem, Eric, Bendell, Johanna, Hidalgo, Manuel, Li, Chung-Pin, Salvo, Marcelo Garrido, Macarulla, Teresa, Sahai, Vaibhav, Sama, Ashwin, Greeno, Edward, Yu, Kenneth H., Verslype,Language:
english
Journal:
Investigational New Drugs
DOI:
10.1007/s10637-018-0580-2
Date:
March, 2018
File:
PDF, 621 KB
english, 2018